USPTO serial 79152852
PANPHARMA
Reviewed by CopyMark Law Group
Reg. 4915903Status 709
- Filing date
- Status date
- Registration date
- Mar 15, 2016
- Examiner
- MARTIN, JENNIFER MCGARRY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PANPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright Epstein Drangel LLP60 E. 42nd Street, Suite 2410New York, NY 10165UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Food for babies; food supplements for humans and animals; medical plasters, materials for dressings; all-purpose disinfectants; preparations for destroying vermin; fungicides; Pharmaceutical and veterinary preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, psychiatric disorder, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; Pharmaceutical preparations for smoking cessation, pharmaceutical sedatives, tranquilizers, depuratives for the body; sanitary preparations for medical use; Dietetic food and substances for medical or veterinary use, namely, crackers, cakes, soup, meal replacement bars, fruit and vegetable granules adapted for medical use; material for dental fillings and dental impressions; antibiotics, virucides, biocides, bactericides, pharmaceutical and veterinary preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; chemical or pharmaceutical preparations for diagnosis for medical and veterinary purposes, namely, diagnostic preparations for medical and veterinary use; Adjuvants for medical and veterinary purposes, namely for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; chemical or chemical-pharmaceutical products and preparations for medical and veterinary purposes, namely, chemical reagents for medical or veterinary purposes; remedies for human and animal medicine, namely natural remedy preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; antibiotics, antibiotic preparations; hormones for medical purposes, preparations containing hormones for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; injectable pharmaceutical preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; tapes and strips for medical and veterinary diagnostic purposes, namely, medical diagnostic test strips for use in the field of gynecology and urology; self-diagnosis tapes and strips for medical purposes for use in the field of gynecology and urology; articles for medical and surgical dressings namely surgical tapes, surgical adhesives, surgical and medical dressings; additives for vaccines, namely, vaccine stablilizers; oral vaccine preparations; vaccines against flu; vaccines against pneumococcal infections; vaccines for human use; vaccines for veterinary use; medicated preparations for skin care and treatment; pharmaceutical preparations for skin care for animals; sanitizing preparations for hospital use; disinfectants for medical apparatus and instruments; disinfectants for medical use; disinfectants for hand wash for medical purposes; medicines for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; tonics medicines for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of nutritional supplements; therapeutic drugs and agents, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; medicines for veterinary use, namely vaccines for use on domestic animals and livestock for veterinary purposes; medicines for veterinary use, namely, antiparasitic collars for animals, antiparasitic preparations, analgesics, general anesthetics, antiseptics, anti-uric preparations; chemical reagents for diagnosis for medical, veterinary and therapeutic purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2025 | Further Decision Processed by IB | — | |
| Mar 18, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 18, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 18, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 16, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Nov 20, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 30, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 30, 2022 | C71T | CANCELLED SECTION 71 | — |
| Mar 15, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 6, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 6, 2021 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jun 14, 2017 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 28, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 10, 2017 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 10, 2017 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 18, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 17, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 17, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 15, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 25, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 15, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 9, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2016 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 4, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 29, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 29, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 9, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 9, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 9, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 20, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 12, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 29, 2015 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 28, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 15, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 15, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 22, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 22, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 20, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 19, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 13, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 13, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 14, 2014 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 9, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |